Andrew Lawrence Taylor Health Sciences Acquisitions Corp 2 (HSAQ) insider trading activity

Andrew Lawrence Taylor is Chief Financial Officer of Health Sciences Acquisitions Corp 2. Currently has a direct ownership of 451,493 shares of HSAQ, which is worth approximately $0. The most recent transaction as insider was on Jan 02, 2026, when has been sold 3,452 shares (Common Stock, par value $0.0001 per share) at a price of $4.31 per share, resulting in proceeds of $14,878. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 451K

3.26% 3M change

30.88% 12M change

Total Value Held $0

Andrew Lawrence Taylor Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	SELL Payment of exercise price or tax liability	$14,878 $4.31 p/Share	3,452 Reduced 0.76%	451,493 Common Stock, par valu...
Dec 10 2025	SELL Payment of exercise price or tax liability	$40,488 $4.67 p/Share	8,670 Reduced 1.87%	454,945 Common Stock, par valu...
Nov 25 2025	SELL Payment of exercise price or tax liability	$16,429 $5.35 p/Share	3,071 Reduced 0.66%	463,615 Common Stock, par valu...
Sep 17 2025	SELL Payment of exercise price or tax liability	$39,610 $2.46 p/Share	16,102 Reduced 3.34%	466,686 Common Stock, par valu...
Aug 25 2025	BUY Open market or private purchase	$5,100 $2.55 p/Share	2,000 Added 0.41%	482,788 Common Stock, par valu...
Aug 07 2025	BUY Grant, award, or other acquisition	-	80,000 Added 14.27%	480,788 Common Stock, par valu...
Jun 11 2025	SELL Payment of exercise price or tax liability	$88,460 $3.14 p/Share	28,172 Reduced 6.57%	400,788 Common Stock, par valu...

Apr 04 2025	BUY Grant, award, or other acquisition	-	84,000 Added 16.38%	428,960 Common Stock, par valu...
Dec 19 2024	BUY Open market or private purchase	$4,830 $4.83 p/Share	1,000 Added 0.29%	344,960 Common Stock, par valu...
Dec 12 2024	SELL Payment of exercise price or tax liability	$173,047 $5.03 p/Share	34,403 Reduced 9.09%	343,960 Common Stock, par valu...
May 08 2024	BUY Grant, award, or other acquisition	-	100,000 Added 20.9%	378,363 Common Stock, par valu...
Jul 20 2023	BUY Grant, award, or other acquisition	-	278,363 Added 50.0%	278,363 Common Stock, par valu...

Also insider at

MOTS

Motus GI Holdings, Inc. Healthcare

Chief Financial Officer

ALT